CLINICAL_TRIALS
research
· 2016-03-14
Clinical Trial Update: The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration
Summary
This clinical trial update examines how genetic polymorphisms in ABCB1, CYP3A4, CYP3A5, POR and other factors influence tacrolimus blood concentration in kidney…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Taiwan University Hospital | Conditions: Kidney Transplantation, Liver Transplantation | Status: UNKNOWN